YPrime schließt sich dem Global Compact der Vereinten Nationen an und verpflichtet sich, seine nachhaltigen Geschäftspraktiken den UN-Zielen anzupassen
17. Dezember 2024 09:58 ET
|
Y-Prime, LLC
MALVERN, Pennsylvania, Dec. 17, 2024 (GLOBE NEWSWIRE) -- YPrime der führende Pionier in der Technologie klinischer Studien, hat heute sein formelles Engagement der Vereinten Nationen (UN) Global...
YPrime s’engage à respecter le Pacte mondial des Nations Unies et à aligner ses pratiques commerciales durables sur les objectifs de l’ONU
17. Dezember 2024 09:58 ET
|
Y-Prime, LLC
MALVERN, Pennsylvanie, 17 déc. 2024 (GLOBE NEWSWIRE) -- YPrime, entreprise pionnière de la technologie des essais cliniques, a annoncé aujourd’hui son engagement formel à respecter le Pacte...
YPrime Commits to United Nations Global Compact, Pledging to Align its Sustainable Business Practices with UN Goals
17. Dezember 2024 09:57 ET
|
Y-Prime, LLC
YPrime pledges to United Nations Global Compact, expanding its program of sustainable business practices.
YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
25. September 2024 09:00 ET
|
Y-Prime, LLC
YPrime releases report on site technology experiences, offering sponsors insights to improve trial efficiency by aligning eCOA platforms with user needs.
YPrime Recognized as Trailblazer in Patient Engagement by Everest Group
24. September 2024 08:42 ET
|
Y-Prime, LLC
YPrime has been recognized as a Trailblazer in patient engagement by Everest Group for its innovative solutions that enhance clinical trial participation.
YPrime bringt bahnbrechende eCOA-Plattform zur Beschleunigung von Implementierungen um bis zu 30 % auf den Markt
24. Juli 2024 22:46 ET
|
Y-Prime, LLC
MALVERN, Pennsylvania, July 25, 2024 (GLOBE NEWSWIRE) -- YPrime, der führende Pionier im Bereich der Technologie für klinische Studien, gab heute die Einführung seiner hochmodernen SaaS-Plattform...
YPrime lance sa plateforme eCOA révolutionnaire qui accélérera de 30 % les mises en œuvre
24. Juli 2024 22:46 ET
|
Y-Prime, LLC
MALVERN, Pennsylvanie, 25 juill. 2024 (GLOBE NEWSWIRE) -- YPrime, pionnière dans le domaine des technologies pour les essais cliniques, a annoncé aujourd'hui le lancement de sa plateforme SaaS eCOA...
YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
24. Juli 2024 09:00 ET
|
Y-Prime, LLC
YPrime releases groundbreaking eCOA platform to revolutionize the clinical trial landscape.
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
25. Juni 2024 08:00 ET
|
Y-Prime, LLC
New YPrime research report sheds light on how technology can help solve challenges in endocrinology clinical trials.
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
21. Mai 2024 08:00 ET
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.